Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

After an average follow-up period of 6.3 years, older adults on levothyroxine had a greater loss of both total body bone mass and bone density.

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to ...

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasise the need to ...

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone ...